Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Inflammation and depression are closely inter-related; inflammation induces symptoms of depression and, conversely, depressed mood and stress favor an inflammatory phenotype. The mechanisms that mediate the ability of inflammation to induce symptoms of depression are intensively studied at the preclinical level. This review discusses how it has been possible to build animal models of inflammation-induced depression based on clinical data and to explore critical mechanisms downstream of inflammation. Namely, we focus on the ability of inflammation to increase the activity of the tryptophan-degrading enzyme, indoleamine 2,3 dioxygenase, which leads to the production of kynurenine and downstream neuroactive metabolites. By acting on glutamatergic neurotransmission, these neuroactive metabolites play a key role in the development of depression-like behaviors. An important outcome of the preclinical research on inflammation-induced depression is the identification of potential novel targets for antidepressant treatments, which include targeting the kynurenine system and production of downstream metabolites, altering transport of kynurenine into the brain, and modulating glutamatergic transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Self-citationA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 1×
“, 2005), several meta analyses support the association between depression and proinflammatory cytokines (Howren et al., 2009; Dowlati et al., 2010).”
BackgroundAssociations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Brown, T. A., Campbell, L. A., Lehman, C. L., Grisham, J. R., & Mancill, R. B. (2001) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.110.4.585 · Cited by 1,562
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365 · cited 1×
“Healthy human subjects given an inflammatory agent, such as endotoxin or typhoid vaccination, show a significant reduction in mood and increased anxiety (Reichenberg et al., 2001; Wright et al., 2005; Eisenberger et al., 2009, 2010).”
BackgroundO'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278 · cited 2×
“This review will discuss the current state of research on inflammation-induced depression, what is known about the mechanisms, and possible novel targets for the treatment of inflammation-induced depression.”
BackgroundSelf-citationGold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · cited 1×
“Physically ill patients with chronic inflammation have an improvement in mood when given treatments that target inflammatory cytokines, such as the TNF-antagonist infliximab (Tyring et al., 2006; Feldman et al., 2008).”
BackgroundTowards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
Cited by
Sex differences in depression: Insights from clinical and preclinical studies
Eid, R. S., Gobinath, A. R., & Galea, L. A. M. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.01.006 · Cited by 457
Yuan, N., Chen, Y., Xia, Y., Dai, J., & Liu, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0570-y · Cited by 428
Caraci, F., Spampinato, S. F., Morgese, M. G., Tascedda, F., Salluzzo, M. G., Giambirtone, M. C., Caruso, G., Munafò, A., Torrisi, S. A., Leggio, G. M., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.007 · Cited by 172
Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders
Bhattacharya, A., & Jones, D. N. C. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.08.015 · Cited by 105
Interleukin-1 β-Targeted Treatment Strategies in Inflammatory Depression: Toward Personalized Care
Ellul, P., Boyer, L., Groc, L., Leboyer, M., & Fond, G. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12656 · Cited by 65
Alexakis, C., Kumar, S., Saxena, S., & Pollok, R. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14171 · Cited by 69
“Conversely, inflammation may also promote depression through the up-regulation of inflammatory cytokines and intermediates.(45) Whether small changes at a cellular level in response to psychological stress actually translate to an objective increase in clinical markers of disease activity is more difficult to establis…”
BackgroundJeon, S.-A., Lee, E., Hwang, I., Han, B., Park, S., Son, S., Yang, J., Hong, S., Kim, C. H., Son, J., et al. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx065 · Cited by 62
“To minimize the overlap with sickness response, we performed behavioral tests after 24 hours of LPS injection similar to experimental designs from previous reports (Dantzer et al., 2008; Remus and Dantzer, 2016).”
MethodInterleukin-10 Level Is Associated with Post-Stroke Depression in Acute Ischaemic Stroke Patients
Chi, C.-H., Huang, Y.-Y., Ye, S.-Z., Shao, M.-M., Jiang, M.-X., Yang, M.-Y., Wu, Q., Shao, B., & Li, X.-M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.06.037 · Cited by 50
Mello, B. S. F., Chaves Filho, A. J. M., Custódio, C. S., Cordeiro, R. C., Miyajima, F., de Sousa, F. C. F., Vasconcelos, S. M. M., de Lucena, D. F., & Macedo, D. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.04.009 · Cited by 45
Prophylactic (R,S)-ketamine selectively protects against inflammatory stressors
Mastrodonato, A., Cohensedgh, O., LaGamma, C. T., McGowan, J. C., Hunsberger, H. C., & Denny, C. A. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112238 · Cited by 48
Brubaker, M., Kapadia, S., Maletic, V., Chambers, J., Watling, C., & Citrome, L. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s501207 · Cited by 7
Metadata
- Authors
- Remus, J. L., & Dantzer, R.
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-03-29
- Volume
- 19
- Issue
- 9
- Pages
- pyw028
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2330962235
- Cited by
- 164
- References
- 63
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.